Prospectus

Rapport Therapeutics, Inc. Filed 2026-10-30 Acc 0001193125-26-439863

Documents 1

2026-10-30 8-K Material agreement · Results of operations · New debt or obligation · Unregistered share sale
2026-10-30 424B5 Prospectus
2026-10-30 424B5 Prospectus
2026-10-30 4 Director bought 969,480 shares at $21.00 ($20,359,080)
2026-10-29 305B2 305B2
2026-10-28 FWP Free Writing Prospectus
2026-10-27 424B5 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d348288d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…